2nd Quarter - Termination

HEALTHFUTURES, LLC for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$30,000
Expenses
—
Terminated
Jun 30, 2011

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#, Genomics and Personalized Medicine Act; No Bill#, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, America Invents Act

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institute of Standards & Technology (NIST); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1249 (112th)

Medical/Disease Research/Clinical Labs MED

Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, American Invents Act

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —

Contacted: Natl Institute of Standards & Technology (NIST); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.